Strumento inattivo

Azioni Genzyme Corporation

Azioni

Prezzo di chiusura Nasdaq Altri mercati azionari
- ^USD	-

GENZYME CORP.GNL : Mipomersen Data Presented at European Atherosclerosis Society Congress	28/06/11
Genzyme : succès de l'OPE de Sanofi-aventis.	04/04/11
GENZYME CORP.GNL : Genzyme Board Unanimously Recommends that Shareholders Accept sanofi-aventis Revised Offer and Tender Shares	07/03/11
Genzyme : Sanofi-aventis modifie son offre.	07/03/11
GENZYME CORP.GNL : Genzyme Completes Sale of Pharmaceuticals Business to International Chemical Investors Group	01/03/11

Settore

	Variaz. 1 gen.	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	-2,31%	103 Mrd
REGENERON PHARMACEUTICALS, INC.	+0,56%	95,28 Mrd
ARGENX SE	+1,69%	22,15 Mrd
BIONTECH SE	-17,37%	21,02 Mrd
GENMAB A/S	-9,30%	18,15 Mrd
WUXI APPTEC CO., LTD.	-41,01%	16,73 Mrd
BEIGENE, LTD.	-14,85%	16,05 Mrd
NEUROCRINE BIOSCIENCES, INC.	+3,21%	13,68 Mrd
SAREPTA THERAPEUTICS, INC.	+33,54%	12,17 Mrd